NEW YORK (GenomeWeb News) – Shares in Beckman Coulter were down approximately 7.7 percent, or $4.39, at $52.61 in mid-afternoon trading today after the company reported a decrease in second-quarter sales and net income.
As reported by GenomeWeb News this morning, total revenues declined to $616 million, from $619 in the same period last year. Beckman blamed the lower-than-expected revenues on lagging sales in the Asian market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.